PERSPECTA

News from every angle

Back to headlines

AI-Developed Drug Reverses Biological Age in Clinical Trial

An experimental drug developed from scratch by AI algorithms, Rentosertib, reduced the biological age of patients with a rare lung disease by 3-4 years in a study published in Nature Biotechnology.

PostShare